Impact of a Nurse Implemented Sedation and Analgesia Algorithm in Surgical Intensive Care Unit
ALGOSEDA
1 other identifier
observational
200
1 country
1
Brief Summary
To show that the nurse implementation of a sedation and analgesia algorithm is beneficial to the patient in terms of sedative drugs reduction and thus overall decrease in duration of mechanical ventilation and the morbidity and mortality which is associated with it, without altering patient comfort and tolerance of the environment. This, compared to the less frequent assessments by doctors and thus regular adjustments during the day as opposed to a fixed drug dose.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 9, 2017
CompletedFirst Posted
Study publicly available on registry
June 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedJune 14, 2017
June 1, 2017
3 years
June 9, 2017
June 13, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Duration of mechanical ventilation
Duration between endotracheale intubation and extubation
baseline
Eligibility Criteria
Mechanically ventilated patients under sedation predicted to last 48hrs or more and aged over 18 years can be included.
You may qualify if:
- Any patient sedated, intubated, ventilated whose anticipated duration of sedation is more than 48 hours.
- Age greater than 18 years.
You may not qualify if:
- Patient under guardianship or \<18.
- Comatose, intracranial hypertension, brain damage, Acute respiratory distress syndrom, acute severe asthma (therapeutic sedation), Post Cardiac Arrest care, Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
POTTIER
Caen, 14033, France
Study Officials
- PRINCIPAL INVESTIGATOR
Véronique POTTIER, MD
department of anesthesia and intensive care, caen university hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2017
First Posted
June 14, 2017
Study Start
December 1, 2014
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
June 14, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will not share